Norethindrone and ethinyl estradiol and ferrous fumarate
These highlights do not include all the information needed to use NORETHINDRONE and ETHINYL ESTRADIOL TABLETS (CHEWABLE) and FERROUS FUMARATE TABLETS safely and effectively. See Full Prescribing Information for NORETHINDRONE and ETHINYL ESTRADIOL TABLETS (CHEWABLE) and FERROUS FUMARATE TABLETS. NORETHINDRONE and ETHINYL ESTRADIOL tablets (chewable) and FERROUS FUMARATE tablets, for oral use Initial U.S. Approval: 1975
Approved
Approval ID
1f7a19f1-fd30-4bd2-aab6-926d911d2579
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Feb 15, 2023
Manufacturers
FDA
Naari Pte Limited
DUNS: 659345996
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
norethindrone and ethinyl estradiol and ferrous fumarate tablet
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code79929-005
Application NumberANDA207066
Product Classification
M
Marketing Category
C73584
G
Generic Name
norethindrone and ethinyl estradiol and ferrous fumarate tablet
Product Specifications
Effective DateFebruary 15, 2023
FDA Product Classification